Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1991 Jul;73(3):342–347.

Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.

R A Jones 1, S J Richards 1, D Patel 1, C S Scott 1
PMCID: PMC1384553  PMID: 1831793

Abstract

Natural killer (NK) cell cytotoxicity constitutes an important component of the host immune defence system. The NK effector cell has been relatively well defined in terms of immunophenotypic characteristics, but in contrast to the functional T-cell receptor molecule associated with major histocompatibility complex (MHC)-restricted cytotoxic activity, the NK cell receptor has not to date been defined. However, several studies have suggested that the beta 2-microglobulin (beta 2m) molecule is functionally associated with NK cell activity. Using various heterospecific and monoclonal antibodies, this study has shown that intact rabbit IgG antibody bound either directly or indirectly to peripheral mononuclear cell (PMNC) effector populations significantly reduced their lytic activity against K562 targets. Substitution of F(ab)2 fragments for rabbit IgG antibodies, or the use of monoclonal antibodies alone, failed to reduce peripheral blood mononuclear cell (PMNC) lytic activity. Addition of non-NK cell components labelled with rabbit anti-beta 2m to purified NK-enriched effector cell populations also suppressed K562 lysis. In contrast, pre-treatment of a NK-enriched PMNC fraction with rabbit anti-beta 2m enhanced target lysis. These results strongly suggest that antibody-induced suppression of PMNC NK activity is mediated via rabbit Fc attached to co-existing non-NK cells in the mononuclear fraction, and are inconsistent with the previously suggested functional association between NK activity and membrane beta 2m.

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnstable C. J., Bodmer W. F., Brown G., Galfre G., Milstein C., Williams A. F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978 May;14(1):9–20. doi: 10.1016/0092-8674(78)90296-9. [DOI] [PubMed] [Google Scholar]
  2. Brodsky F. M., Bodmer W. F., Parham P. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol. 1979 Jul;9(7):536–545. doi: 10.1002/eji.1830090709. [DOI] [PubMed] [Google Scholar]
  3. Brodsky F. M., Parham P., Barnstable C. J., Crumpton M. J., Bodmer W. F. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3–61. doi: 10.1111/j.1600-065x.1979.tb00288.x. [DOI] [PubMed] [Google Scholar]
  4. Hogan P. G., Basten A. What are killer cells and what do they do? Blood Rev. 1988 Mar;2(1):50–58. doi: 10.1016/0268-960x(88)90008-2. [DOI] [PubMed] [Google Scholar]
  5. Hokland M., Heron I., Berg K., Hokland P. Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol. 1982 Sep 1;72(1):40–51. doi: 10.1016/0008-8749(82)90281-7. [DOI] [PubMed] [Google Scholar]
  6. Horton J. J., Holden C. A., Ward P. J., MacDonald D. M., Sanderson A. R. Exploitation of phylogenetic distance in cell surface immune labeling: studies with beta 2-microglobulin. J Invest Dermatol. 1985 Feb;84(2):96–99. doi: 10.1111/1523-1747.ep12274979. [DOI] [PubMed] [Google Scholar]
  7. Lampson L. A., Fisher C. A., Whelan J. P. Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J Immunol. 1983 May;130(5):2471–2478. [PubMed] [Google Scholar]
  8. Müllbacher A., King N. J. Target cell lysis by natural killer cells is influenced by beta 2-microglobulin expression. Scand J Immunol. 1989 Jul;30(1):21–29. doi: 10.1111/j.1365-3083.1989.tb01184.x. [DOI] [PubMed] [Google Scholar]
  9. Parham P., Bodmer W. F. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature. 1978 Nov 23;276(5686):397–399. doi: 10.1038/276397a0. [DOI] [PubMed] [Google Scholar]
  10. Petrányi G. G., Pócsik E., Kotlán B., Görög G., Benczur M. Regulatory function of cell surface molecules CD2-, LFA- and beta 2-microglobulin in natural killer cell activity. Mol Immunol. 1986 Nov;23(11):1275–1279. doi: 10.1016/0161-5890(86)90164-1. [DOI] [PubMed] [Google Scholar]
  11. Winfield J. B., Lobo P. I., Hamilton M. E. Fc receptor heterogeneity: immunofluorescent studies of B, T, and "third population" lymphocytes in human blood with rabbit IgG b4/anti-b4 complexes. J Immunol. 1977 Nov;119(5):1778–1784. [PubMed] [Google Scholar]
  12. Zola H., McNamara P. J., Moore H. A., Smart I. J., Brooks D. A., Beckman I. G., Bradley J. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol. 1983 Jun;52(3):655–664. [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES